Cansema Suppositories
 
Cansema Suppositories
Code 1350 -- Price: $49.95
Net Wt.: 16 g. (2,000 mg. x 8)
Main Cansema Page
AO Natural Suppositories
Presently Not Available


Cansema Suppository - overview {xtypo_dropcap}T{/xtypo_dropcap}his product is the suppository version of Cansema Black Topical Salve. As we state on our introductory page to AO Natural Suppositories, the idea for this product came from a medical doctor in Chicago (USA), who has used a diluted version of the salve to treat colorectal cancers in friends, family, and colleagues -- an application, he indicates, that works quite successfully. (His technique actually involves the use of a bladder catheter, which is used to deposit the Cansema formula high into the descending colon, near the splenic flexure. Note that this is not a protocol developed by Alpha Omega Labs; we do not promote its use; and we make mention of this for informational purposes only).

Though clinicians have reported back to us on successful uses of Cansema Salve and both Cansema Tonics (original, and Tonic III), for several years now in both rectal and vaginal applications, we have not promoted these methodologies. In fact, we have made it clear since first making Cansema Salve that the product should not (unless under the advice of a qualified health care practitioner) be applied to mucous membrane.

Although posing no toxicological challenges when used as directed herein, Cansema Suppository usage poses pain response considerations that deserve special attention when applied within "circulatory range" of cancer growth accessible by the suppository's substrate material. For this reason, we do not recommend the use of this product without the care and oversight of a qualified health care practitioner. In most countries, this will be a medical doctor (M.D.) or osteopath (D.O.). In the presence of substantial cancer growth, this product, like the topical salve that inspired it, can produce a substantial pain response. The use of narcotics class analgesics will, in many cases, be required.

 

Back to Source Page